Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network - Archive ouverte HAL Access content directly
Journal Articles Annals of Oncology Year : 2020

Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network

(1) , (2) , (3) , (4) , (3) , (5) , (6) , (7) , (1) , (4) , (8) , (9) , (10) , (11) , (12) , (13) , (14) , (14) , (15) , (16) , (17) , (18, 19) , (20) , (21) , (11) , (17) , (22) , (8, 1) , (23) , (24) , (6) , (1) , (25) , (26) , (27) , (9) , (3) , (2) , (28) , (29) , (26) , (30) , (31) , (1) , (32) , (33) , (34) , (35, 36)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
Judith V.M.G. Bovee
  • Function : Author
  • PersonId : 907032
J Desai
  • Function : Author
N Hindi
  • Function : Author
H Joensuu
  • Function : Author
Y-K Kang
  • Function : Author
J Martín
  • Function : Author

Abstract

Sarcomas are a heterogeneous group of malignancies with mesenchymal lineage differentiation. The discovery of neurotrophic tyrosine receptor kinase (NTRK) gene fusions as tissue-agnostic oncogenic drivers has led to new personalized therapies for a subset of patients with sarcoma in the form of tropomyosin receptor kinase (TRK) inhibitors. NTRK gene rearrangements and fusion transcripts can be detected with different molecular pathology techniques, while TRK protein expression can be demonstrated with immunohistochemistry. The rarity and diagnostic complexity of NTRK gene fusions raise a number of questions and challenges for clinicians. To address these challenges, the World Sarcoma Network convened two meetings of expert adult oncologists and pathologists and subsequently developed this article to provide practical guidance on the management of patients with sarcoma harboring NTRK gene fusions. We propose a diagnostic strategy that considers disease stage and histologic and molecular subtypes to facilitate routine testing for TRK expression and subsequent testing for NTRK gene fusions.
Fichier principal
Vignette du fichier
S0923753420422975.pdf (7.04 Mo) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-03046627 , version 1 (24-10-2022)

Licence

Attribution - NonCommercial - CC BY 4.0

Identifiers

Cite

G D Demetri, Antonescu C R, B Bjerkehagen, Judith V.M.G. Bovee, K Boye, et al.. Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network. Annals of Oncology, 2020, 31 (11), pp.1506-1517. ⟨10.1016/j.annonc.2020.08.2232⟩. ⟨hal-03046627⟩

Collections

FNCLCC IGR
11 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More